IVIg in the treatment of patients with factor VIII inhibitors.
Sultan
Y
Y
Centre des Hémophiles, Hôpital Cochin, Paris, France.
Nydegger
U
U
Kazatchkine
M D
MD
Rossi
F
F
Algiman
M
M
Dietrich
G
G
D000293:Adolescent; D000328:Adult; D000368:Aged; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use; D001323:Autoantibodies / Q000276:immunology; D005169:Factor VIII / Q000037:antagonists & inhibitors / Q000276:immunology; D005260:Female; D006467:Hemophilia A / Q000097:blood / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000276:immunology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D000888:Antibodies, Anti-Idiotypic; D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D005169:Factor VIII